Global Dermatology OTC Medications Market Growth 2022-2028
As the global economy mends, the 2021 growth of Dermatology OTC Medications will have significant change from previous year. According to our latest study, the global Dermatology OTC Medications market size is USD million in 2022 from USD 12500 million in 2021, with a change of % between 2021 and 2022. The global Dermatology OTC Medications market size will reach USD 15820 million in 2028, growing at a CAGR of 3.4% over the analysis period.
The United States Dermatology OTC Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermatology OTC Medications market, reaching US$ million by the year 2028. As for the Europe Dermatology OTC Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dermatology OTC Medications players cover Bayer, GSK, Teva, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology OTC Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
External Use
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology OTC Medications Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dermatology OTC Medications by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dermatology OTC Medications by Country/Region, 2017, 2022 & 2028
2.2 Dermatology OTC Medications Segment by Type
2.2.1 External Use
2.2.2 Oral
2.3 Dermatology OTC Medications Sales by Type
2.3.1 Global Dermatology OTC Medications Sales Market Share by Type (2017-2022)
2.3.2 Global Dermatology OTC Medications Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dermatology OTC Medications Sale Price by Type (2017-2022)
2.4 Dermatology OTC Medications Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Other
2.5 Dermatology OTC Medications Sales by Application
2.5.1 Global Dermatology OTC Medications Sale Market Share by Application (2017-2022)
2.5.2 Global Dermatology OTC Medications Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dermatology OTC Medications Sale Price by Application (2017-2022)
3 Global Dermatology OTC Medications by Company
3.1 Global Dermatology OTC Medications Breakdown Data by Company
3.1.1 Global Dermatology OTC Medications Annual Sales by Company (2020-2022)
3.1.2 Global Dermatology OTC Medications Sales Market Share by Company (2020-2022)
3.2 Global Dermatology OTC Medications Annual Revenue by Company (2020-2022)
3.2.1 Global Dermatology OTC Medications Revenue by Company (2020-2022)
3.2.2 Global Dermatology OTC Medications Revenue Market Share by Company (2020-2022)
3.3 Global Dermatology OTC Medications Sale Price by Company
3.4 Key Manufacturers Dermatology OTC Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermatology OTC Medications Product Location Distribution
3.4.2 Players Dermatology OTC Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dermatology OTC Medications by Geographic Region
4.1 World Historic Dermatology OTC Medications Market Size by Geographic Region (2017-2022)
4.1.1 Global Dermatology OTC Medications Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dermatology OTC Medications Annual Revenue by Geographic Region
4.2 World Historic Dermatology OTC Medications Market Size by Country/Region (2017-2022)
4.2.1 Global Dermatology OTC Medications Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dermatology OTC Medications Annual Revenue by Country/Region
4.3 Americas Dermatology OTC Medications Sales Growth
4.4 APAC Dermatology OTC Medications Sales Growth
4.5 Europe Dermatology OTC Medications Sales Growth
4.6 Middle East & Africa Dermatology OTC Medications Sales Growth
5 Americas
5.1 Americas Dermatology OTC Medications Sales by Country
5.1.1 Americas Dermatology OTC Medications Sales by Country (2017-2022)
5.1.2 Americas Dermatology OTC Medications Revenue by Country (2017-2022)
5.2 Americas Dermatology OTC Medications Sales by Type
5.3 Americas Dermatology OTC Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermatology OTC Medications Sales by Region
6.1.1 APAC Dermatology OTC Medications Sales by Region (2017-2022)
6.1.2 APAC Dermatology OTC Medications Revenue by Region (2017-2022)
6.2 APAC Dermatology OTC Medications Sales by Type
6.3 APAC Dermatology OTC Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dermatology OTC Medications by Country
7.1.1 Europe Dermatology OTC Medications Sales by Country (2017-2022)
7.1.2 Europe Dermatology OTC Medications Revenue by Country (2017-2022)
7.2 Europe Dermatology OTC Medications Sales by Type
7.3 Europe Dermatology OTC Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermatology OTC Medications by Country
8.1.1 Middle East & Africa Dermatology OTC Medications Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dermatology OTC Medications Revenue by Country (2017-2022)
8.2 Middle East & Africa Dermatology OTC Medications Sales by Type
8.3 Middle East & Africa Dermatology OTC Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermatology OTC Medications
10.3 Manufacturing Process Analysis of Dermatology OTC Medications
10.4 Industry Chain Structure of Dermatology OTC Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dermatology OTC Medications Distributors
11.3 Dermatology OTC Medications Customer
12 World Forecast Review for Dermatology OTC Medications by Geographic Region
12.1 Global Dermatology OTC Medications Market Size Forecast by Region
12.1.1 Global Dermatology OTC Medications Forecast by Region (2023-2028)
12.1.2 Global Dermatology OTC Medications Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dermatology OTC Medications Forecast by Type
12.7 Global Dermatology OTC Medications Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Dermatology OTC Medications Product Offered
13.1.3 Bayer Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Dermatology OTC Medications Product Offered
13.2.3 GSK Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Dermatology OTC Medications Product Offered
13.3.3 Teva Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Dermatology OTC Medications Product Offered
13.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Dermatology OTC Medications Product Offered
13.5.3 Novartis Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Dermatology OTC Medications Product Offered
13.6.3 Mylan Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Dermatology OTC Medications Product Offered
13.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Aurobindo
13.8.1 Aurobindo Company Information
13.8.2 Aurobindo Dermatology OTC Medications Product Offered
13.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aurobindo Main Business Overview
13.8.5 Aurobindo Latest Developments
13.9 Galderma
13.9.1 Galderma Company Information
13.9.2 Galderma Dermatology OTC Medications Product Offered
13.9.3 Galderma Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Galderma Main Business Overview
13.9.5 Galderma Latest Developments
13.10 CR SANJIU
13.10.1 CR SANJIU Company Information
13.10.2 CR SANJIU Dermatology OTC Medications Product Offered
13.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CR SANJIU Main Business Overview
13.10.5 CR SANJIU Latest Developments
13.11 Dr. Reddy's
13.11.1 Dr. Reddy's Company Information
13.11.2 Dr. Reddy's Dermatology OTC Medications Product Offered
13.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dr. Reddy's Main Business Overview
13.11.5 Dr. Reddy's Latest Developments
13.12 Lupin
13.12.1 Lupin Company Information
13.12.2 Lupin Dermatology OTC Medications Product Offered
13.12.3 Lupin Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Lupin Main Business Overview
13.12.5 Lupin Latest Developments
13.13 Bausch Health
13.13.1 Bausch Health Company Information
13.13.2 Bausch Health Dermatology OTC Medications Product Offered
13.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Bausch Health Main Business Overview
13.13.5 Bausch Health Latest Developments
13.14 Cipla
13.14.1 Cipla Company Information
13.14.2 Cipla Dermatology OTC Medications Product Offered
13.14.3 Cipla Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Cipla Main Business Overview
13.14.5 Cipla Latest Developments
13.15 Qilu Pharmaceutical
13.15.1 Qilu Pharmaceutical Company Information
13.15.2 Qilu Pharmaceutical Dermatology OTC Medications Product Offered
13.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Qilu Pharmaceutical Main Business Overview
13.15.5 Qilu Pharmaceutical Latest Developments
13.16 Almirall
13.16.1 Almirall Company Information
13.16.2 Almirall Dermatology OTC Medications Product Offered
13.16.3 Almirall Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Almirall Main Business Overview
13.16.5 Almirall Latest Developments
13.17 Lingrui
13.17.1 Lingrui Company Information
13.17.2 Lingrui Dermatology OTC Medications Product Offered
13.17.3 Lingrui Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Lingrui Main Business Overview
13.17.5 Lingrui Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Dermatology OTC Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dermatology OTC Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of External Use
Table 4. Major Players of Oral
Table 5. Global Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 6. Global Dermatology OTC Medications Sales Market Share by Type (2017-2022)
Table 7. Global Dermatology OTC Medications Revenue by Type (2017-2022) & ($ million)
Table 8. Global Dermatology OTC Medications Revenue Market Share by Type (2017-2022)
Table 9. Global Dermatology OTC Medications Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 11. Global Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Table 12. Global Dermatology OTC Medications Revenue by Application (2017-2022)
Table 13. Global Dermatology OTC Medications Revenue Market Share by Application (2017-2022)
Table 14. Global Dermatology OTC Medications Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Dermatology OTC Medications Sales by Company (2020-2022) & (M Units)
Table 16. Global Dermatology OTC Medications Sales Market Share by Company (2020-2022)
Table 17. Global Dermatology OTC Medications Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Dermatology OTC Medications Revenue Market Share by Company (2020-2022)
Table 19. Global Dermatology OTC Medications Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Dermatology OTC Medications Producing Area Distribution and Sales Area
Table 21. Players Dermatology OTC Medications Products Offered
Table 22. Dermatology OTC Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dermatology OTC Medications Sales by Geographic Region (2017-2022) & (M Units)
Table 26. Global Dermatology OTC Medications Sales Market Share Geographic Region (2017-2022)
Table 27. Global Dermatology OTC Medications Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Dermatology OTC Medications Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Dermatology OTC Medications Sales by Country/Region (2017-2022) & (M Units)
Table 30. Global Dermatology OTC Medications Sales Market Share by Country/Region (2017-2022)
Table 31. Global Dermatology OTC Medications Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Dermatology OTC Medications Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 34. Americas Dermatology OTC Medications Sales Market Share by Country (2017-2022)
Table 35. Americas Dermatology OTC Medications Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Dermatology OTC Medications Revenue Market Share by Country (2017-2022)
Table 37. Americas Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 38. Americas Dermatology OTC Medications Sales Market Share by Type (2017-2022)
Table 39. Americas Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 40. Americas Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Table 41. APAC Dermatology OTC Medications Sales by Region (2017-2022) & (M Units)
Table 42. APAC Dermatology OTC Medications Sales Market Share by Region (2017-2022)
Table 43. APAC Dermatology OTC Medications Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Dermatology OTC Medications Revenue Market Share by Region (2017-2022)
Table 45. APAC Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 46. APAC Dermatology OTC Medications Sales Market Share by Type (2017-2022)
Table 47. APAC Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 48. APAC Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Table 49. Europe Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 50. Europe Dermatology OTC Medications Sales Market Share by Country (2017-2022)
Table 51. Europe Dermatology OTC Medications Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Dermatology OTC Medications Revenue Market Share by Country (2017-2022)
Table 53. Europe Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 54. Europe Dermatology OTC Medications Sales Market Share by Type (2017-2022)
Table 55. Europe Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 56. Europe Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Dermatology OTC Medications Sales by Country (2017-2022) & (M Units)
Table 58. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Dermatology OTC Medications Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Dermatology OTC Medications Sales by Type (2017-2022) & (M Units)
Table 62. Middle East & Africa Dermatology OTC Medications Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Dermatology OTC Medications Sales by Application (2017-2022) & (M Units)
Table 64. Middle East & Africa Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Dermatology OTC Medications
Table 66. Key Market Challenges & Risks of Dermatology OTC Medications
Table 67. Key Industry Trends of Dermatology OTC Medications
Table 68. Dermatology OTC Medications Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Dermatology OTC Medications Distributors List
Table 71. Dermatology OTC Medications Customer List
Table 72. Global Dermatology OTC Medications Sales Forecast by Region (2023-2028) & (M Units)
Table 73. Global Dermatology OTC Medications Sales Market Forecast by Region
Table 74. Global Dermatology OTC Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Dermatology OTC Medications Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Dermatology OTC Medications Sales Forecast by Country (2023-2028) & (M Units)
Table 77. Americas Dermatology OTC Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Dermatology OTC Medications Sales Forecast by Region (2023-2028) & (M Units)
Table 79. APAC Dermatology OTC Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Dermatology OTC Medications Sales Forecast by Country (2023-2028) & (M Units)
Table 81. Europe Dermatology OTC Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Dermatology OTC Medications Sales Forecast by Country (2023-2028) & (M Units)
Table 83. Middle East & Africa Dermatology OTC Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Dermatology OTC Medications Sales Forecast by Type (2023-2028) & (M Units)
Table 85. Global Dermatology OTC Medications Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Dermatology OTC Medications Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Dermatology OTC Medications Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Dermatology OTC Medications Sales Forecast by Application (2023-2028) & (M Units)
Table 89. Global Dermatology OTC Medications Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Dermatology OTC Medications Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Dermatology OTC Medications Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Dermatology OTC Medications Product Offered
Table 94. Bayer Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. GSK Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Dermatology OTC Medications Product Offered
Table 99. GSK Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Teva Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Dermatology OTC Medications Product Offered
Table 104. Teva Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Johnson & Johnson Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Dermatology OTC Medications Product Offered
Table 109. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Novartis Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis Dermatology OTC Medications Product Offered
Table 114. Novartis Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Novartis Main Business
Table 116. Novartis Latest Developments
Table 117. Mylan Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 118. Mylan Dermatology OTC Medications Product Offered
Table 119. Mylan Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Mylan Main Business
Table 121. Mylan Latest Developments
Table 122. Sun Pharmaceutical Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 123. Sun Pharmaceutical Dermatology OTC Medications Product Offered
Table 124. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Sun Pharmaceutical Main Business
Table 126. Sun Pharmaceutical Latest Developments
Table 127. Aurobindo Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 128. Aurobindo Dermatology OTC Medications Product Offered
Table 129. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Aurobindo Main Business
Table 131. Aurobindo Latest Developments
Table 132. Galderma Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 133. Galderma Dermatology OTC Medications Product Offered
Table 134. Galderma Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Galderma Main Business
Table 136. Galderma Latest Developments
Table 137. CR SANJIU Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 138. CR SANJIU Dermatology OTC Medications Product Offered
Table 139. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. CR SANJIU Main Business
Table 141. CR SANJIU Latest Developments
Table 142. Dr. Reddy's Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 143. Dr. Reddy's Dermatology OTC Medications Product Offered
Table 144. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Dr. Reddy's Main Business
Table 146. Dr. Reddy's Latest Developments
Table 147. Lupin Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 148. Lupin Dermatology OTC Medications Product Offered
Table 149. Lupin Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Lupin Main Business
Table 151. Lupin Latest Developments
Table 152. Bausch Health Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 153. Bausch Health Dermatology OTC Medications Product Offered
Table 154. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Bausch Health Main Business
Table 156. Bausch Health Latest Developments
Table 157. Cipla Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 158. Cipla Dermatology OTC Medications Product Offered
Table 159. Cipla Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Cipla Main Business
Table 161. Cipla Latest Developments
Table 162. Qilu Pharmaceutical Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 163. Qilu Pharmaceutical Dermatology OTC Medications Product Offered
Table 164. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Qilu Pharmaceutical Main Business
Table 166. Qilu Pharmaceutical Latest Developments
Table 167. Almirall Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 168. Almirall Dermatology OTC Medications Product Offered
Table 169. Almirall Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Almirall Main Business
Table 171. Almirall Latest Developments
Table 172. Lingrui Basic Information, Dermatology OTC Medications Manufacturing Base, Sales Area and Its Competitors
Table 173. Lingrui Dermatology OTC Medications Product Offered
Table 174. Lingrui Dermatology OTC Medications Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Lingrui Main Business
Table 176. Lingrui Latest Developments
List of Figures
Figure 1. Picture of Dermatology OTC Medications
Figure 2. Dermatology OTC Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermatology OTC Medications Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Dermatology OTC Medications Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dermatology OTC Medications Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Oral
Figure 11. Global Dermatology OTC Medications Sales Market Share by Type in 2021
Figure 12. Global Dermatology OTC Medications Revenue Market Share by Type (2017-2022)
Figure 13. Dermatology OTC Medications Consumed in Hospital
Figure 14. Global Dermatology OTC Medications Market: Hospital (2017-2022) & (M Units)
Figure 15. Dermatology OTC Medications Consumed in Drug Store
Figure 16. Global Dermatology OTC Medications Market: Drug Store (2017-2022) & (M Units)
Figure 17. Dermatology OTC Medications Consumed in Other
Figure 18. Global Dermatology OTC Medications Market: Other (2017-2022) & (M Units)
Figure 19. Global Dermatology OTC Medications Sales Market Share by Application (2017-2022)
Figure 20. Global Dermatology OTC Medications Revenue Market Share by Application in 2021
Figure 21. Dermatology OTC Medications Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Dermatology OTC Medications Revenue Market Share by Company in 2021
Figure 23. Global Dermatology OTC Medications Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Dermatology OTC Medications Revenue Market Share by Geographic Region in 2021
Figure 25. Global Dermatology OTC Medications Sales Market Share by Region (2017-2022)
Figure 26. Global Dermatology OTC Medications Revenue Market Share by Country/Region in 2021
Figure 27. Americas Dermatology OTC Medications Sales 2017-2022 (M Units)
Figure 28. Americas Dermatology OTC Medications Revenue 2017-2022 ($ Millions)
Figure 29. APAC Dermatology OTC Medications Sales 2017-2022 (M Units)
Figure 30. APAC Dermatology OTC Medications Revenue 2017-2022 ($ Millions)
Figure 31. Europe Dermatology OTC Medications Sales 2017-2022 (M Units)
Figure 32. Europe Dermatology OTC Medications Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Dermatology OTC Medications Sales 2017-2022 (M Units)
Figure 34. Middle East & Africa Dermatology OTC Medications Revenue 2017-2022 ($ Millions)
Figure 35. Americas Dermatology OTC Medications Sales Market Share by Country in 2021
Figure 36. Americas Dermatology OTC Medications Revenue Market Share by Country in 2021
Figure 37. United States Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Dermatology OTC Medications Sales Market Share by Region in 2021
Figure 42. APAC Dermatology OTC Medications Revenue Market Share by Regions in 2021
Figure 43. China Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Dermatology OTC Medications Sales Market Share by Country in 2021
Figure 50. Europe Dermatology OTC Medications Revenue Market Share by Country in 2021
Figure 51. Germany Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country in 2021
Figure 58. Egypt Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Dermatology OTC Medications Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Dermatology OTC Medications in 2021
Figure 64. Manufacturing Process Analysis of Dermatology OTC Medications
Figure 65. Industry Chain Structure of Dermatology OTC Medications
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
